Psivida wins technology award

By Melissa Trudinger
Thursday, 15 July, 2004

Nanotechnology company Psivida (ASX: PSD) has had its research applying its BioSilicon technology to drug delivery, diagnostics, orthopaedics and tissue engineering recognised with a 2004 Excellence in Research Award from US consulting group Frost & Sullivan.

Frost & Sullivan announced the award in a recently released study focusing on nanomedicine.

Widespread resistance to common antibiotics is increasing: WHO

Increasing resistance to essential antibiotics poses a growing threat to global health, with one...

Dopamine helps our brains to let go of memories

In a discovery that could reshape how we think about memory, researchers at Flinders University...

Vaccine for elephant herpesvirus found to be safe

The vaccine could prevent deadly elephant endotheliotropic herpesvirus in calves — the...

Content from other channels on our network

ECD Turbidity Measurement Sensor

Partnership to create sustainable coupling relays

BMW launches EV battery recycling in Australia

$14K community grant provides water savings for school

Webinar to address EU packaging waste regulation

Seifert Systems Outdoor Series (OC): Precision Cooling for Enclosures in Outdoor Environments

The Inside Scoop: How Fishbowl Boosted Lick Ice Cream's Sweet Success

Bringing the benefits of PCR and automation to high-throughput beverage testing, with the SureTect Automation Platform

Complete snack and confectionery line on show

$340,000 safety spend after fruit packing injury

Report explores Australian perceptions of Medtech access

Vertical healing: redefining health care through high-rise hospital design

Using better network insight to boost productivity in Australian health care

Construction underway on new Redcliffe cancer care centre

Digital health lessons across industries